2000 Nobel Prize in Physiology or Medicine — Carlsson, Greengard, and Kandel: Mapping the Molecular Landscape of Dopamine, Synapses, and Memory

What You'll Learn in This Article

This article explores how the molecular map of the brain’s fundamental language, neural signaling, was completed through the 2000 Nobel Prize in Physiology or Medicine. It covers Arvid Carlsson's establishment of dopamine as a neurotransmitter and the basis for L-DOPA treatment for Parkinson's disease, Paul Greengard's elucidation of the molecular mechanisms of synaptic signaling, and Eric Kandel's discovery of the cellular and molecular mechanisms of learning and memory through experiments on sea slugs (Aplysia). The discoveries of these three prominent neuroscientists form the foundation for the treatment of Parkinson's disease, schizophrenia, depression, addiction, and Alzheimer's disease and marked the beginning of the explosive growth of 21st-century neuroscience.

Beyond Common Knowledge: The Brain's Language is Chemical Signaling and Phosphorylation

From the late 19th century onward, the existence of neurons (Ramon y Cajal and Golgi, 1906 Nobel Prize), the mechanism of neuronal excitation (Hodgkin and Huxley, 1963), and the chemical signaling at synapses (Katz, 1970) were revealed. However, at the end of the 20th century, questions remained: which specific neurotransmitters regulate which functions? What are the detailed molecular mechanisms of synaptic signaling? And how are memories stored in the brain?

Carlsson's Dopamine: Dopamine was long considered merely a precursor to norepinephrine. Carlsson demonstrated that dopamine itself is a neurotransmitter and that it is abundantly distributed in the brain's basal ganglia, the center for motor control. He also observed that administering reserpine to experimental animals depleted dopamine, resulting in symptoms of muscle rigidity, tremors, and motor impairment. He realized that these symptoms were very similar to those of Parkinson's disease.

This completed the picture: Parkinson's disease = dopamine deficiency in the basal ganglia. The treatment was clear: administering L-DOPA (a dopamine precursor) would convert to dopamine in the brain, improving symptoms. L-DOPA remains the standard drug for Parkinson's disease today. Carlsson's discovery changed the lives of millions of Parkinson's patients.

Greengard's Synaptic Signaling: He elucidated in detail what happens within a neuron after a neurotransmitter binds to it. In particular, he showed that cAMP-dependent protein kinase (PKA) is a key regulator of synaptic responses. The signaling cascade is as follows: signal transduction cascade → phosphorylation → regulation of ion channels, receptors, and synaptic vesicles.

Kandel's Memory: At Columbia University, Kandel used the sea slug (Aplysia) to elucidate the cellular and molecular mechanisms of learning and memory. The sea slug is an ideal model organism because it has a small number of neurons (approximately 20,000), making it possible to trace individual neural circuits. Kandel's discoveries:

• Short-term memory: Repeated stimulation increases the release of neurotransmitters at the synapse. This involves a cascade of events: increased cAMP → activation of PKA → phosphorylation of K+ channels → decreased K+ efflux → sustained action potentials → increased Ca2+ influx → increased neurotransmitter release. This is a temporary change that occurs only through the phosphorylation of existing proteins.
• Long-term memory: Strong and repeated stimulation activates cAMP → PKA → CREB transcription factor → synthesis of new proteins → expansion of synaptic structure. This is a sustained change that requires the synthesis of new proteins. Blocking protein synthesis interferes with the formation of long-term memory.

In terms of computer science, this is remarkably similar to a cache-disk tiered storage system.

• Short-term memory = Cache expansion: Temporarily increases the neurotransmitter release rate of existing synapses. Tuning parameters of existing infrastructure.
• Long-term memory = Disk recompilation: Reconfigures the synaptic structure itself by synthesizing new proteins. Recompiling source code and deploying a new executable.

This tiered structure is the foundation for how we understand the principles of learning, training, and memory enhancement today. This is why we need to sleep or engage in repeated rehearsal to remember something for a long time – because it takes time to complete the synthesis of new proteins.

The Zeitgeist: The Dawn of the New Millennium and Korea's Zenith

The year 2000 was a symbolic year marking the end of the 20th century and the beginning of the 21st century, and it also represented a peak in Korea's international standing.

In Korean history, the North-South Summit Meeting (June 13-15) took place in Pyongyang, with President Kim Dae-jung and National Defense Commission Chairman Kim Jong-il meeting face-to-face. This was the first meeting between the leaders of North and South Korea in 55 years of division. The June 15th South-North Joint Declaration was announced. Later, in October, President Kim Dae-jung was awarded the Nobel Peace Prize – the first Korean to receive a Nobel Prize – in recognition of his efforts to improve North-South relations and his commitment to democracy. In September, the North and South Korean athletes entered the Sydney Olympics together, creating a moving moment. Samsung Electronics began its ascent as the world's leading semiconductor company, marking a decisive turning point for Korea's rise as a semiconductor powerhouse.

In world history, the world successfully navigated the Y2K problem on January 1, 2000. On June 26, the draft of the Human Genome Project was announced by Presidents Clinton and Blair, marking a new horizon in life sciences. In November, the US presidential election between George W. Bush and Al Gore was marred by controversy over the recount in Florida. The Napster Supreme Court case marked a turning point in copyright reform.

In this pivotal year, the Nobel Committee recognized the three neuroscientists who had elucidated the fundamental language of the brain. In the year that Korea established itself as a mature nation on the world stage, the mature understanding of the brain was also recognized.

Arvid Carlsson: The Dopamine Discoverer of Gothenburg, Sweden

Arvid Carlsson (1923-2018) was a Swedish pharmacologist. He received his Ph.D. from the University of Lund in 1951 and served as a professor at the University of Gothenburg from 1951 to 1989, where he conducted most of his research. After 1989, he became a professor emeritus.

Carlsson's pivotal experiment involved rabbits treated with reserpine. Reserpine depletes neurotransmitters (dopamine, norepinephrine, and serotonin) in neuronal synapses. He observed that these rabbits exhibited symptoms similar to Parkinson's disease. He then demonstrated that administering L-DOPA (a dopamine precursor) improved the symptoms, laying the crucial foundation for the treatment of Parkinson's disease.

Carlsson later expanded his research to schizophrenia, demonstrating that excessive dopamine or overactivity of dopamine receptors is associated with the positive symptoms of schizophrenia (delusions and hallucinations). He established the concept that antipsychotic drugs block dopamine D2 receptors. This forms the basis for our understanding of drugs such as risperidone, olanzapine, clozapine, and aripiprazole today.

He also contributed to the understanding of serotonin signaling, demonstrating that serotonin is involved in the regulation of emotions, anxiety, and depression, providing the conceptual basis for the development of selective serotonin reuptake inhibitors (SSRIs).

Paul Greengard: Mapping the Molecular Mechanisms of Synaptic Signaling

Paul Greengard (1925-2019) was an American biochemist. He received his Ph.D. from Johns Hopkins University in 1953 and served as a professor at Yale University from 1968 to 1983 and at the Rockefeller University from 1983.

Greengard completed the detailed picture of what happens in a neuron after a neurotransmitter binds to it. In particular, he discovered DARPP-32, a phosphorylated protein, and elucidated the detailed mechanisms of dopamine signaling.

He established that the cascade of events is as follows: cAMP → PKA → phosphorylation of target proteins → regulation of ion channels and receptors. This showed that the synapse is not just a point where events occur, but a sophisticated computational unit.

This understanding became the basis for precisely mapping the targets of psychiatric drugs. SSRIs for depression, antipsychotics for schizophrenia, stimulants for ADHD, and acetylcholinesterase inhibitors for Alzheimer's disease are all based on this map.

Eric Kandel: Unraveling Learning and Memory with the Sea Slug

Eric R. Kandel (1929- ) is an American biochemist. He was born in Vienna, Austria, to a Jewish family, and immigrated to the United States after the Nazi annexation of Austria in 1938. He received his M.D. from New York University in 1956 and has served as a professor at Columbia University's Department of Neurobiology and Behavior since 1974.

Kandel's creative choice was to use the sea slug (Aplysia) as a model for studying the cellular and molecular mechanisms of learning and memory. The sea slug is an ideal model organism because it has a small number of neurons (approximately 20,000), making it possible to trace individual neural circuits. The neurons are large and easily identifiable, and the sea slug exhibits simple learning behaviors (habituation, sensitization, and classical conditioning). It is possible to trace the cellular and molecular mechanisms of learning and memory at the level of individual synapses.

Kandel's discoveries:

Cellular Mechanisms of Short-Term Memory: Repeated stimulation increases the amount of neurotransmitter (glutamate) released at the synapse of sensory neurons. This involves the following cascade of events: cAMP → PKA → phosphorylation of K+ channels → decreased K+ efflux → sustained action potentials → increased Ca2+ influx → increased neurotransmitter release. This is a temporary change that occurs through changes in existing proteins.

Cellular Mechanisms of Long-Term Memory: Strong and repeated stimulation activates cAMP → PKA → translocation to the nucleus → phosphorylation of the CREB transcription factor → expression of new genes → synthesis of new proteins → expansion of the synaptic structure. This is a sustained change that requires the synthesis of new proteins. Administration of protein synthesis inhibitors (such as puromycin) interferes with the formation of long-term memory.

Structural Observation of Synaptic Expansion: It was confirmed by electron microscopy that the synapses of the learned sensory neurons are actually physically expanded. Memory is stored in the physical structure of the synapse.

He later demonstrated that this principle applies to mammals (mice and humans). This is now the theoretical basis for the development of treatments for Alzheimer's disease and cognitive impairment. His autobiography, "In Search of Memory" (2006), became a worldwide bestseller and a symbol of popular science books on the brain.

CS Framework: Event Broker and Cache-Disk Tiered Storage

Reconstructing the neural signaling and memory system in terms of computer science yields the following diagram.

Neuron = Service Instance: Each neuron is a service with its own state and response logic.

Synapse = Event Broker: The synapse is the point where events are published and subscribed.

Neurotransmitter = Event Payload: Dopamine, glutamate, GABA, and serotonin are specific event types.

Receptor = Event Listener: The receptor recognizes specific neurotransmitters.

cAMP-PKA Cascade = Middleware Processing: Synaptic events pass through middleware and are processed.

Short-Term Memory = Cache Expansion (LRU Algorithm): The processing speed of frequently accessed event paths is temporarily increased. Tuning parameters of existing infrastructure.

Long-Term Memory = Disk Recompilation (Deploying New Executables): CREB transcription factor is activated, new genes are expressed, new proteins are synthesized, and the synaptic structure is physically expanded. New source code is compiled and a new executable is deployed.

Protein Synthesis Inhibition = Deployment Failure: If new proteins cannot be synthesized, long-term memory is not formed. The source code exists, but compilation fails.

Sleep and Rehearsal Required = Deployment Latency: It takes time for the synaptic structure to be completed. This is why we need to sleep or engage in repeated learning.

Drug Targets = Broker Manipulation:

• L-DOPA: Replenishes dopamine deficiency in Parkinson's disease by supplying a dopamine precursor.
• Antipsychotics: Block dopamine D2 receptors, treating schizophrenia.
• SSRIs: Inhibit serotonin reuptake, sustaining serotonin signaling, treating depression.
• Tricyclic Antidepressants: Inhibit the reuptake of multiple neurotransmitters.
• Stimulants (amphetamine): Increase the release of dopamine and norepinephrine, treating ADHD.
• Acetylcholinesterase Inhibitors (donepezil): Sustain acetylcholine, treating Alzheimer's disease.
• Amantadine: Treats Parkinson's disease and cognitive impairment.

Understanding Neuroplasticity = Principles of System Reconfiguration: The principles of brain reconfiguration in learning and memory are now the theoretical basis for rehabilitation medicine, cognitive training, and stroke recovery.

The limitation of this analogy: The actual brain is a much more complex probabilistic network, with multiple circuits operating in parallel. It is more sophisticated than a simple event broker and cache model.

Academic Impact: The Explosion of Millennial Neuroscience

This discovery fundamentally reshaped the fields of neuroscience and psychiatry.

Standardization of Parkinson's Disease Treatment: L-DOPA (FDA approved in 1968) remains the only fundamental treatment for Parkinson's disease to this day. More recently, Deep Brain Stimulation (DBS) – inserting electrodes into the basal ganglia to regulate circuits – has become a standard option. Gene therapy and stem cell therapy are also in clinical trials.

Expansion of Psychiatric Pharmacology: Drugs targeting neurotransmitters such as dopamine, serotonin, and norepinephrine are now the cornerstone of treatment for most psychiatric disorders.

• Schizophrenia: Risperidone, Olanzapine, Clozapine, Aripiprazole
• Depression: SSRIs (e.g., Fluoxetine), SNRIs, TCAs
• Anxiety: Benzodiazepines, SSRIs
• ADHD: Methylphenidate, Amphetamine
• Autism Spectrum Related: Risperidone, Aripiprazole

Alzheimer's and Cognitive Impairment Research: Acetylcholinesterase inhibitors (Donepezil, Rivastigmine, Galantamine), NMDA modulators (Memantine), and, more recently, anti-amyloid antibodies (Lecanemab, Aducanumab).

Understanding Addiction: Understanding the dopamine reward circuit provides a unified perspective on addictions to alcohol, nicotine, opioids, stimulants, and behavioral addictions.

The Explosion of Millennial Neuroscience: In the decade following this award, neuroscience experienced explosive growth. National-scale brain research projects such as the US BRAIN Initiative (2013), the European Human Brain Project (2013), Japan's Brain/MINDS (2014), China's China Brain Project (2016), and South Korea's Basic Plan for Promoting Brain Research have emerged. It is an era of brain mapping, circuit elucidation, and the integration of artificial intelligence and the brain.

Korea's Legacy and Today

The impact of this legacy in Korea is widespread. Neuroscience research labs at Seoul National University, Yonsei University, KAIST, POSTECH, and the Institute for Basic Science (IBS) are among the top in the world. The establishment of the Korea Brain Research Institute (KBRI, 2011) in Daegu has established a national brain research infrastructure.

Clinical Practice: At Seoul National University Hospital, Samsung Seoul Hospital, Asan Medical Center, and Yonsei Severance Hospital, treatments such as L-DOPA and DBS for Parkinson's disease are at the highest level in the world. In psychiatry, SSRIs and antipsychotics are standard treatments. Early diagnosis and treatment of Alzheimer's disease are standard practice in university hospitals.

Korean Schizophrenia Genetics: Large-scale research on Korean schizophrenia genetics has been conducted at Seoul National University and Samsung Seoul Hospital.

Popularization of Neuroscience: Following the publication of Kandel's "In Search of Memory," popular science books on neuroscience have also become popular in Korea. Works by Jung Jae-seung and Park Moon-ho have broadened public awareness.

Why is it Important?

The legacy of these three individuals is the establishment of the understanding that "the brain functions through specific chemical signals and phosphorylation cascades, and memory involves the physical restructuring of synapses."

This discovery drew the horizon of millennial neuroscience. As the last Nobel Prize of the 20th century, it was a synthesis of 20th-century neuroscience and a starting point for 21st-century brain science.

The Foundation of Clinical Psychopharmacology: A unified understanding and treatment of Parkinson's disease, schizophrenia, depression, and addiction.

The Complementary Contributions of Three Independent Individuals: Kandel's focus on neurotransmitters, Greenough's focus on synaptic molecular mechanisms, and Kandel's focus on memory cells and molecular mechanisms have been combined complementarily to complete a comprehensive picture of the brain.

Kandel's Jewish Immigrant Story: The story of a boy who immigrated to the United States to escape the Nazis reaching the pinnacle of neuroscience 60 years later. It is a representative story of immigration and diversity in science in the late 20th century.

The flow of neuroscience and psychiatry after this award continues as follows:

• 2014, O'Keefe and Moser: Grid cells for spatial cognition in the brain
• 2021, Patapoutian and Julius: Receptors for touch and temperature sensation
• 2013~, BRAIN Initiative: National-scale brain research projects

Clinical application of this discovery:

• Standard treatment for Parkinson's disease: L-DOPA/Carbidopa, DBS
• Standard treatment for Schizophrenia: Risperidone, Olanzapine, Aripiprazole
• Standard treatment for Depression: SSRI (Fluoxetine), SNRI
• Treatment for Alzheimer's disease: Donepezil, Memantine, recent antibody therapies

Batch 8 Conclusion: This concludes the 20-part Batch 8 (1981-2000). The next batch will begin with 2001 (Hartwell, Nurse, and Hunt on the Cell Cycle).

→ Previous: 1999, Blobel → Next: [2001, Entering Batch 9]